BDBM658474 1-((1R,5R,6S)-6-methyl-6-((6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl)oxy)-2-azabicyclo[3.2.0]heptan-2-yl)prop-2-en-1-one 1-((1S,5S,6R)-6-methyl-6-((6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl)oxy)-2-azabicyclo[3.2.0]heptan-2-yl)prop-2-en-1-one::US20240083900, Example 190
SMILES Cn1cc(cn1)-c1cn2nccc2c(O[C@@]2(C)C[C@@H]3[C@H]2CCN3C(=O)C=C)n1
InChI Key InChIKey=RZOINIBREFUBMF-UHFFFAOYSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 2 hits for monomerid = 658474
Affinity DataKd: 0.310nMAssay Description:Inhibition of human full-length wild type BTK (M1 to S659 residues) expressed in mammalian expression systemMore data for this Ligand-Target Pair
Affinity DataIC50: 1nMAssay Description:The purpose of the BTK in vitro assay is to determine compound potency against BTK through the measurement of IC50. Compound inhibition is measured a...More data for this Ligand-Target Pair
